Dr Puma Sundaresan

Clinical Lecturer
Medicine, Central Clinical School

C39 - Royal Prince Alfred Hospital
The University of Sydney
NSW 2006 Australia

T: 02 9515 8057
E:

Publications

2014 | 2012 | 2011 | 2010 | 2008

2014

   
  • Sundaresan, P., Turner, S., Kneebone, A., Pearse, M., Fraser-Browne, C., Woo, H. (2014), Do Screening Trial Recruitment Logs Accurately Reflect the Eligibility Criteria of a Given Clinical Trial? Early Lessons from the RAVES 0803 Trial. Clinical Oncology. 26(6), 348-352. [Abstract]

2012

   
  • Sundaresan, P., Hruby, G., Hamilton, A., Hong, A., Boyer, M., Chatfield, M., Thompson, J. (2012), Definitive Radiotherapy or Chemoradiotherapy in the Treatment of Merkel Cell Carcinoma. Clinical Oncology. 24(9), e131-e136. [Abstract]

2011

   
  • Sundaresan, P., Turner, S., Kneebone, A., Pearse, M., Butow, P. (2011), Evaluating the utility of a patient decision aid for potential participants of a prostate cancer trial (RAVES-TROG 08.03). Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 101(3), 521-4. [Abstract]

2010

   
  • Sundaresan, P., Yeghiaian-Alvandi, R., Gebski, V. (2010), Prognostic index to identify patients who may not benefit from whole brain radiotherapy for multiple brain metastases from lung cancer. Journal of Medical Imaging and Radiation Oncology. 54(1), 69-75. [Abstract]

2008

   
  • Sundaresan, P., Jayamohan, J. (2008), Stereotactic radiotherapy for the treatment of neurosarcoidosis involving the pituitary gland and hypothalamus. Journal of Medical Imaging and Radiation Oncology. 52(6), 622-626. [Abstract]